Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Sulfur 7% Versus Permethrin 5% in Scabies
NCT07822672Phase 4Completed
- Sponsor
- Can Tho University of Medicine and Pharmacy
- Start
- Jun 2024
- Primary completion
- May 2026
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in scabies comparing Arm 1 (Sulfur 7%) with Arm 2 (Permethrin 5%) (2 arms). Primary endpoint: Complete cure rate at 4 weeks. Started Jun 2024; status: completed.
02
Drugs
sulfur ointmentpermethrin
03
Conditions
scabies
Beyond the preview
Go deeper on NCT07822672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07822672.